Content-Length: 258021 | pFad | https://cancerletter.com/trials-and-tribulations/20241115_5/

How we improved the treatment of Hodgkin lymphoma - The Cancer Letter

How we improved the treatment of Hodgkin lymphoma

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Hodgkin lymphoma has long been a model disease in the field of oncology—one of the first diseases we learned to cure with radiation and ultimately chemotherapy. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Alex Herrera, MD
Chief, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Los Angeles
Table of Contents

YOU MAY BE INTERESTED IN

Alex Herrera, MD
Chief, Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Los Angeles

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login









ApplySandwichStrip

pFad - (p)hone/(F)rame/(a)nonymizer/(d)eclutterfier!      Saves Data!


--- a PPN by Garber Painting Akron. With Image Size Reduction included!

Fetched URL: https://cancerletter.com/trials-and-tribulations/20241115_5/

Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy